Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 4 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies.
Cancers (Basel). 2022 Jul 14;14(14):3431. doi: 10.3390/cancers14143431.
Cancers (Basel). 2022.
PMID: 35884491
Free PMC article.
Review.
Validation and clinical application of transactivation assays for RUNX1 variant classification.
Decker M, Agarwal A, Benneche A, Churpek J, Duployez N, Duvall A, Ernst MPT, Förster A, Høberg-Vetti H, Hofmann I, Nash M, Raaijmakers MHGP, Tvedt THA, Vlachos A, Schlegelberger B, Illig T, Ripperger T.
Decker M, et al.
Blood Adv. 2022 Jun 14;6(11):3195-3200. doi: 10.1182/bloodadvances.2021006161.
Blood Adv. 2022.
PMID: 35026845
Free PMC article.
Item in Clipboard
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M, Lammens T, Ferster A, Erlacher M, Yoshimi A, Niemeyer CM, Ernst MPT, Raaijmakers MHGP, Duployez N, Flaum A, Steinemann D, Schlegelberger B, Illig T, Ripperger T.
Decker M, et al.
Leukemia. 2021 Nov;35(11):3304-3308. doi: 10.1038/s41375-021-01200-w. Epub 2021 Mar 10.
Leukemia. 2021.
PMID: 33692461
Free PMC article.
No abstract available.
Item in Clipboard
Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Decker M, Lammens T, Ferster A, Erlacher M, Yoshimi A, Niemeyer CM, Ernst MPT, Raaijmakers MHGP, Duployez N, Flaum A, Steinemann D, Schlegelberger B, Illig T, Ripperger T.
Decker M, et al.
Leukemia. 2022 Dec;36(12):2949. doi: 10.1038/s41375-022-01709-8.
Leukemia. 2022.
PMID: 36258014
Free PMC article.
No abstract available.
Item in Clipboard
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF.
Huge N, Reinkens T, Buurman R, Sandbothe M, Bergmann A, Wallaschek H, Vajen B, Stalke A, Decker M, Eilers M, Schäffer V, Dittrich-Breiholz O, Gürlevik E, Kühnel F, Schlegelberger B, Illig T, Skawran B.
Huge N, et al. Among authors: decker m.
Cancer Cell Int. 2022 May 16;22(1):192. doi: 10.1186/s12935-022-02582-2.
Cancer Cell Int. 2022.
PMID: 35578240
Free PMC article.
Item in Clipboard
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
Gallagher EJ, Moore H, Lacouture ME, Dent SF, Farooki A, Goncalves MD, Isaacs C, Johnston A, Juric D, Quandt Z, Spring L, Berman B, Decker M, Hortobagyi GN, Kaffenberger BH, Kwong BY, Pluard T, Rao R, Schwartzberg L, Broder MS.
Gallagher EJ, et al. Among authors: decker m.
NPJ Breast Cancer. 2024 Jan 31;10(1):12. doi: 10.1038/s41523-024-00613-x.
NPJ Breast Cancer. 2024.
PMID: 38297009
Free PMC article.
Item in Clipboard
Cite
Cite